Targeting a gene in pancreatic beta cells could disrupt the chain of events that leads to the immune system destroying those cells and causing type 1 diabetes
Lori Solomon, M.D. ’99, M.P.H. ’09, Salomon Amar, D.D.S., Ph.D., and Gregory R. Veillette, M.D were highlighted for their work in patient care and research.